Radiopharm Theranostics Management
Management criteria checks 2/4
Radiopharm Theranostics' CEO is Riccardo Canevari, appointed in Sep 2021, has a tenure of 2.67 years. total yearly compensation is A$3.18M, comprised of 25.9% salary and 74.1% bonuses, including company stock and options. directly owns 2.14% of the company’s shares, worth A$386.14K. The average tenure of the management team and the board of directors is 2.3 years and 2.3 years respectively.
Key information
Riccardo Canevari
Chief executive officer
AU$3.2m
Total compensation
| CEO salary percentage | 25.9% |
| CEO tenure | 2.7yrs |
| CEO ownership | 2.1% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.3yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$47m |
| Sep 30 2023 | n/a | n/a | -AU$41m |
| Jun 30 2023 | AU$3m | AU$825k | -AU$35m |
| Mar 31 2023 | n/a | n/a | -AU$30m |
| Dec 31 2022 | n/a | n/a | -AU$26m |
| Sep 30 2022 | n/a | n/a | -AU$28m |
| Jun 30 2022 | AU$3m | AU$631k | -AU$30m |
Compensation vs Market: Riccardo's total compensation ($USD2.09M) is above average for companies of similar size in the Australian market ($USD294.64K).
Compensation vs Earnings: Riccardo's compensation has been consistent with company performance over the past year.
CEO
Riccardo Canevari
2.7yrs
Tenure
AU$3,180,964
Compensation
Mr. Riccardo Canevari is Managing Director & Chief Executive Officer since September 13, 2021 and Director at Radiopharm Theranostics Limited. He was Chief Commercial Officer of Advanced Accelerator Applic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 3.3yrs | AU$459.97k | 20.85% A$ 3.8m | |
| MD, CEO & Director | 2.7yrs | AU$3.18m | 2.14% A$ 386.1k | |
| Chief Operating Officer | 1.9yrs | AU$1.29m | no data | |
| Chief Medical Officer & Scientific Advisory Board Chair | no data | AU$1.46m | 0.27% A$ 49.6k | |
| Chief Business Officer | no data | AU$504.74k | 0.22% A$ 40.0k | |
| CFO, Company Secretary & Director | no data | AU$88.39k | 1.38% A$ 250.3k | |
| Senior Vice President of Clinical Operations | 2.4yrs | no data | no data | |
| Senior Vice President of Regulatory Strategy | 2.2yrs | no data | no data | |
| Senior VP of Chemistry | 1.3yrs | no data | no data | |
| Company Secretary | 2.6yrs | no data | no data |
2.3yrs
Average Tenure
67yo
Average Age
Experienced Management: RAD's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 3.3yrs | AU$459.97k | 20.85% A$ 3.8m | |
| MD, CEO & Director | no data | AU$3.18m | 2.14% A$ 386.1k | |
| Chief Medical Officer & Scientific Advisory Board Chair | no data | AU$1.46m | 0.27% A$ 49.6k | |
| CFO, Company Secretary & Director | less than a year | AU$88.39k | 1.38% A$ 250.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 3.1yrs | AU$537.00k | 0.19% A$ 34.9k | |
| Non-Executive Director | 1.9yrs | AU$101.40k | 0.016% A$ 2.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 2.3yrs | AU$65.00k | 0.015% A$ 2.6k |
2.3yrs
Average Tenure
Experienced Board: RAD's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.